Hyperuricemia
📧 Sign up to get email alerts when something new happens for Hyperuricemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-02-21FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ULORIC (febuxostat) from Takeda Pharmaceuticals America, Inc., reflecting an additional regulato…
-
FDA approval · 2018-12-03FDA Approved: ALLOPURINOL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Allopurinol filed by Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Prednisone for Heart Failure Patients With Hyperuricemia [Phase 2, Phase 3]
A phase 2/3 clinical trial explored prednisone for patients with heart failure and hyperuricemia; the study has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types) [Phase 2]
Phase 2 study update for FYU-981 in hyperuricemia completed.
-
CLINICAL_TRIALS research · 2018-06-19Clinical Trial Update: Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia
This entry outlines a clinical trial evaluating musculoskeletal ultrasound in people with asymptomatic hyperuricemia. It is sponsored by the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Hyperuricemia and Left Ventricular Diastolic Function
A terminated clinical trial sponsored by National Defense Medical Center in Taiwan investigated hyperuricemia and metabolic syndrome in rela…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: Prevalence of Hyperuricemia in Pakistan
This clinical trial update reports on the prevalence of hyperuricemia in Pakistan, sponsored by OBS Pakistan; the current status of the stud…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level [Phase 1]
A Phase 1 multiple-dose study of SHR4640 in male subjects with high serum uric acid levels has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Effect of Hyperuricaemia on Chronic Renal Disease [Phase 4]
Phase 4 trial update exploring the impact of hyperuricaemia on chronic renal disease.
-
FDA label_change · 2018-02-06FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ULORIC (febuxostat) submitted by Takeda Pharmaceuticals America, Inc. The supplemental action pe…
-
FDA approval · 2017-08-15FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ULORIC (febuxostat) submitted by Takeda Pharmaceuticals America, Inc. The submission status …
-
CLINICAL_TRIALS research · 2017-07-14Clinical Trial Update: The Intervention of Multi-vitamin With Minerals to Hyperuricemia [Phase 4]
This document reports a Phase 4 clinical trial evaluating a multivitamin with minerals for hyperuricemia, with the current status listed as …
-
CLINICAL_TRIALS research · 2017-05-11Clinical Trial Update: Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients [NA]
Clinical trial update noting completion of a study evaluating febuxostat for hyperuricemia in patients on hemodialysis.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
Completed trial evaluating rasburicase for chemotherapy- or malignancy-induced hyperuricemia in leukemia and lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout [Phase 2]
Phase 2 clinical trial evaluating the effect of topiroxostat on urinary albumin excretion in early-stage diabetic nephropathy with hyperuric…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Multiple Dose Study of SHR4640 in Healthy Subjects [Phase 1]
A Phase 1 multiple-dose study of SHR4640 in healthy subjects has completed, assessing safety and pharmacokinetics in the context of gout and…
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients [Phase 2]
Phase 2 study of URC102 to assess efficacy and safety in gout and hyperuricemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Single Dose Study of SHR4640 in Healthy Subjects [Phase 1]
This report notes the completion of a Phase 1 single-dose study of SHR4640 in healthy subjects to assess safety and pharmacokinetics for gou…
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Study of FYU-981 in Hyperuricemia With or Without Gout [Phase 2]
Phase 2 trial of FYU-981 in hyperuricemia with or without gout has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Long-term Prednisone Use for End-stage Heart Failure [Phase 2, Phase 3]
A clinical trial update on long-term prednisone use for end-stage heart failure, currently in Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Study of URC102 to Assess the Safety and Efficacy in Gout Patients [Phase 2]
A Phase 2 study of URC102 by JW Pharmaceutical evaluated safety and efficacy in patients with gout and hyperuricemia. The trial has complete…
-
CLINICAL_TRIALS research · 2016-10-25Clinical Trial Update: Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients [NA]
Clinical trial update comparing renal protective effects of febuxostat versus benzbromarone in Chinese patients with chronic kidney disease …
-
FDA approval · 2016-09-09FDA Approved: ALLOPURINOL SODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Allopurinol Sodium (generic) from Hikma Pharmaceuticals USA Inc. under an ANDA.
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: Purine Metabolism Enzyme SNP to Uric Acid Production
A clinical trial evaluating the link between a purine metabolism enzyme SNP and uric acid production in gout and hyperuricemia has completed…
-
CLINICAL_TRIALS research · 2016-08-26Clinical Trial Update: Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy [NA]
Clinical trial evaluating Febuxostat for prevention of cerebral and cardiorenovascular events in people with hyperuricemia; trial status is …